Lotte Boon

Experience - Stibbe advises Azerion, a high-growth, profitable, digital entertainment and media company, on its business combination with European FinTech IPO Company 1 B.V. (EFIC1), a SPAC listed on Euronext Amsterdam, pursuant to which Azerion will become a public company with an initial enterprise value of €1.3 billion.

Experience - Stibbe advises EssilorLuxottica on its mandatory public offer on the remaining shares in GrandVision.

Experience - Stibbe acts as lead counsel to InPost on its IPO and listing on Euronext Amsterdam.

Experience - Stibbe is advising EssilorLuxottica S.A. on the acquisition of a 76.7% stake in Grandvision N.V. from HAL Holding N.V., which will be followed by a mandatory offer for all shares in the company, resulting in a total transaction value of more than EUR 7 billion.

Experience - Stibbe advises Investcorp, a leading global manager of alternative investments, on the sale of SecureLink, one of the largest dedicated cybersecurity infrastructure and managed services providers in Europe, to global telecoms group Orange for an enterprise value of €515 million.

Experience - Stibbe advised Abry Partners, a private equity fund, and its portfolio-company KORE, the independent global IoT leader, on the acquisition of ASPIDER-NGI, a leading provider of advanced connectivity, core network, and eSIM solutions.

Experience - Stibbe advises APG and a joint venture partner on the acquisition of an approximate 33% interest in HHR Euro C.V. from their joint venture partner Host Hotels & Resorts Inc.

Experience - Stibbe advised Intertrust on a EUR 500 million notes offering and a new facilities agreement.  

Experience - Stibbe advises Tata Communications, a leading global digital infrastructure provider, on the acquisition of Teleena, a Netherlands-based Internet of Things (IoT) connectivity specialist and mobile virtual network enabler (MVNE).  

Experience - Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR").